insights_auto
Why is SOBI down 3,30%?
Dive Deeperchevron_right
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK 480,20
arrow_downward
-3,30%(-16,40) 1D
10 ພ.ຈ., 17 ໂມງ 29 ນາທີ 32 ວິນາທີ GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEK 485,00
High
SEK 493,40
Low
SEK 476,80
Mkt. cap
171,74 ຕື້
Avg. vol.
361,32 ພັນ
Volume
717,56 ພັນ
P/E ratio
25,51
52-wk high
SEK 507,00
52-wk low
SEK 314,40
EPS
SEK 18,83
Shares outstanding
357,64 ລ້ານ
No. of employees
2 ພັນ
Open
SEK 485,00
High
SEK 493,40
Low
SEK 476,80
Mkt. cap
171,74 ຕື້
Avg. vol.
361,32 ພັນ
Volume
717,56 ພັນ
P/E ratio
25,51
52-wk high
SEK 507,00
52-wk low
SEK 314,40
EPS
SEK 18,83
Shares outstanding
357,64 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)
CEOGuido Oelkers
Employees2,21 ພັນ
Founded1939
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitesobi.com